Showing results (881-890 of 1,066) with videos related to

Sort By:
Pageof 107
Bioorganic & Medicinal Chemistry Letters|March 14, 2013
N-substituted azaindoles as potent inhibitors of Cdc7 kinaseMarian C Bryan, James R Falsey, Mike Frohn, et al.
Practical Neurology|May 9, 2022
Neurology and the histiocytoses: a case of Rosai-Dorfman-Destombes diseaseAntonia S Carroll, Carolynne M Doherty, Julian Blake, et al.
Journal of Medicinal Chemistry|April 1, 1991
New inhibitors of human renin that contain novel replacements at the P2 siteA M Doherty, J S Kaltenbronn, J P Hudspeth, et al.
Thyroid : Official Journal of the American Thyroid Association|November 4, 2020
Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and OutcomeKristine S Wong, Fei Dong, Milhan Telatar, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 15, 2024
Protecting and promoting editorial independenceKamaldeep Bhui, Aileen O'Brien, Rachel Upthegrove, et al.
Journal of Medicinal Chemistry|March 20, 1992
Renin inhibitors containing alpha-heteroatom amino acids as P2 residuesJ T Repine, J S Kaltenbronn, A M Doherty, et al.
Annals of Surgery|May 1, 2002
Gastrointestinal manifestations of multiple endocrine neoplasia type 2Mark S Cohen, John E Phay, Charlotte Albinson, et al.
Journal of Cardiovascular Pharmacology|January 1, 1995
Structure-activity relationships of a novel series of orally active nonpeptide ETA and ETA/B endothelin receptor-selective antagonistsA M Doherty, W C Patt, J Repine, et al.
Journal of Medicinal Chemistry|July 20, 1992
Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitorsW C Patt, H W Hamilton, M D Taylor, et al.
Pageof 107